Pyridoxamine does not reduce arterial stiffness in an 8-week randomized double-blind placebo-controlled intervention trial with abdominally obese individuals.

Van den Eynde MDG, van der Bruggen MM, Houben AJHM, Reesink KD, Spronck B, Delhaas T, Scheijen JJLJM, Miyata T, Schalkwijk CG

Open source

DOI
10.1111/dom.16524
Published
2025 Sep
Container
Diabetes, obesity & metabolism
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/dom.16524,
  title = {Pyridoxamine does not reduce arterial stiffness in an 8-week randomized double-blind placebo-controlled intervention trial with abdominally obese individuals.},
  author = {Van den Eynde MDG and van der Bruggen MM and Houben AJHM and Reesink KD and Spronck B and Delhaas T and Scheijen JJLJM and Miyata T and Schalkwijk CG},
  year = {2025},
  journal = {Diabetes, obesity \& metabolism},
  doi = {10.1111/dom.16524},
  url = {https://doi.org/10.1111/dom.16524}
}

RIS

TY  - JOUR
TI  - Pyridoxamine does not reduce arterial stiffness in an 8-week randomized double-blind placebo-controlled intervention trial with abdominally obese individuals.
AU  - Van den Eynde MDG
AU  - van der Bruggen MM
AU  - Houben AJHM
AU  - Reesink KD
AU  - Spronck B
AU  - Delhaas T
AU  - Scheijen JJLJM
AU  - Miyata T
AU  - Schalkwijk CG
PY  - 2025
JO  - Diabetes, obesity & metabolism
DO  - 10.1111/dom.16524
UR  - https://doi.org/10.1111/dom.16524
ER  - 

APA

MDG, V. D. E., MM, V. D. B., AJHM, H., KD, R., B, S., T, D., JJLJM, S., T, M., & CG, S. (2025). Pyridoxamine does not reduce arterial stiffness in an 8-week randomized double-blind placebo-controlled intervention trial with abdominally obese individuals.. Diabetes, obesity & metabolism. https://doi.org/10.1111/dom.16524

Source records